<DOC>
	<DOCNO>NCT00088816</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , S-1 cisplatin , work different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . Giving combination chemotherapy surgery may shrink tumor remove . PURPOSE : This phase II trial study well give S-1 together cisplatin work treat patient undergo surgery stage IV gastric cancer .</brief_summary>
	<brief_title>S-1 Cisplatin Before Surgery Treating Patients With Stage IV Gastric Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine efficacy feasibility neoadjuvant chemotherapy comprise S-1 cisplatin patient stage IV gastric adenocarcinoma . - Determine overall survival patient treat regimen . Secondary - Determine time progression type initial recurrence patient treat regimen . - Determine tumor response patient treat regimen . - Determine mortality morbidity relate treatment patient . - Determine toxicity regimen patient . OUTLINE : This multicenter study . Patients receive oral S-1 day 1-21 cisplatin IV 2 hour day 8 . Treatment repeat every 35 day 2 course absence disease progression unacceptable toxicity . Patients undergo gastrectomy lymphadenectomy . Patients resume oral S-1 surgery . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm gastric adenocarcinoma Stage IV disease meet 1 follow stag criterion accord Japanese gastric cancer classification : T4 , N2 T4 , N3 P1 , CY1 CT scan laparoscopic staging require PATIENT CHARACTERISTICS : Age 20 Performance status ECOG 01 Life expectancy Not specify Hematopoietic WBC ≥ 4,000/mm^3 AND &lt; 12,000/mm^3 Granulocyte count ≥ 2,000/mm^3 Platelet count ≥ 100,000/mm^3 Hemoglobin ≥ 9.0 g/dL Hepatic AST ALT ≤ 2.5 time upper limit normal Bilirubin ≤ 1.5 mg/dL Renal Creatinine clearance ≥ 50 mL/min Pulmonary PaO_2 ≥ 70 mm Hg room air Other Able swallow oral medication PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy gastric cancer Endocrine therapy Not specify Radiotherapy No prior radiotherapy gastric cancer Surgery No prior surgery gastric cancer Other No prior therapy gastric cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>adenocarcinoma stomach</keyword>
</DOC>